Lymphoseek
Phase 3Terminated 0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Head and Neck Squamous Cell Carcinoma (HNSCC)
Conditions
Head and Neck Squamous Cell Carcinoma (HNSCC)
Trial Timeline
May 1, 2009 → Aug 1, 2013
NCT ID
NCT00911326About Lymphoseek
Lymphoseek is a phase 3 stage product being developed by Navidea Biopharmaceuticals for Head and Neck Squamous Cell Carcinoma (HNSCC). The current trial status is terminated. This product is registered under clinical trial identifier NCT00911326. Target conditions include Head and Neck Squamous Cell Carcinoma (HNSCC).
What happened to similar drugs?
11 of 20 similar drugs in Head and Neck Squamous Cell Carcinoma (HNSCC) were approved
Approved (11) Terminated (0) Active (9)
Hype Score Breakdown
Clinical
17
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01106040 | Phase 3 | Completed |
| NCT00911326 | Phase 3 | Terminated |
| NCT00671918 | Phase 3 | Completed |
Competing Products
20 competing products in Head and Neck Squamous Cell Carcinoma (HNSCC)